Kestra Medical Technologies

Kestra Medical Technologies operates at the intersection of digital healthcare, smart wearables, mobile connectivity, and lifesaving medical technologies. The company specializes in developing innovative and intuitive medical devices designed to protect and support at-risk cardiac patients. Its flagship product, the ASSURE Wearable Cardioverter Defibrillator (WCD) system, offers integrated sensing, autonomous detection, and highly effective defibrillation therapy. The system includes a remote patient data platform for robust management and a patient application to engage users in their recovery and care. Kestra serves electrophysiology and cardiology clinicians, as well as at-risk cardiac patients, primarily in the United States. The company generates revenue through the sale and service of its medical devices, as well as through partnerships with health plans that cover the ASSURE system. Kestra's business model focuses on enhancing patient outcomes and expanding access to its lifesaving technologies.

Keywords: wearable defibrillator, cardiac recovery, digital healthcare, smart wearables, patient engagement, autonomous detection, defibrillation therapy, remote patient management, FDA approved, health plan partnerships.